Company Filing History:
Years Active: 2006
Title: The Innovative Contributions of Moses B I Goddard
Introduction
Moses B I Goddard, based in Tiverton, Rhode Island, is a prominent inventor known for his groundbreaking work in the field of cell-based delivery systems. With one patent to his name, Goddard has made significant strides in advancing medical technology, particularly in the realm of encapsulated cell-based therapies.
Latest Patents
Goddard's patent, titled ARPE-19 as a platform cell line for encapsulated cell-based delivery, showcases the versatility and robustness of ARPE-19 cells. These cells are evaluated as a platform for both encapsulated and unencapsulated delivery technologies. The findings indicate that ARPE-19 cells possess several desirable traits: they remain viable under stringent conditions, can be genetically modified to secrete specific proteins, exhibit a long lifespan, originate from human cells, maintain good in vivo device viability, deliver effective quantities of growth factors, trigger minimal host immune reactions, and are non-tumorigenic.
Career Highlights
Goddard is currently affiliated with Neurotech S.A., a company focused on the development of innovative therapies to restore vision and other functionalities using cell-based technologies. His work at Neurotech S.A. emphasizes the potential of leveraging active biological agents for therapeutic advantages.
Collaborations
Throughout his career, Moses B I Goddard has collaborated with notable professionals in the field, including Weng Tao and David H Rein. These partnerships have contributed to further advancements in the research and application of cell-based delivery systems, enhancing the impact of their collective work on medical science.
Conclusion
Moses B I Goddard exemplifies the spirit of innovation in the biotechnological field. His contributions through the patent of ARPE-19 cells signify a leap forward in encapsulated cell-based delivery technologies. With ongoing collaboration and research, Goddard and his colleagues at Neurotech S.A. continue to pave the way for future advancements in medical treatments and therapies.